TR201906195T4 - Niemann pıck hastalığının teşhisi için metot. - Google Patents

Niemann pıck hastalığının teşhisi için metot. Download PDF

Info

Publication number
TR201906195T4
TR201906195T4 TR2019/06195T TR201906195T TR201906195T4 TR 201906195 T4 TR201906195 T4 TR 201906195T4 TR 2019/06195 T TR2019/06195 T TR 2019/06195T TR 201906195 T TR201906195 T TR 201906195T TR 201906195 T4 TR201906195 T4 TR 201906195T4
Authority
TR
Turkey
Prior art keywords
pick disease
niemann pick
subject
diagnosing niemann
diagnosing
Prior art date
Application number
TR2019/06195T
Other languages
English (en)
Turkish (tr)
Inventor
Rolfs Arndt
Mascher Hermann
Original Assignee
Centogene Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centogene Ag filed Critical Centogene Ag
Publication of TR201906195T4 publication Critical patent/TR201906195T4/tr

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01JELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
    • H01J49/00Particle spectrometers or separator tubes
    • H01J49/0027Methods for using particle spectrometers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G01N2405/04Phospholipids, i.e. phosphoglycerides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G01N2405/08Sphingolipids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
TR2019/06195T 2013-05-14 2014-05-14 Niemann pıck hastalığının teşhisi için metot. TR201906195T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13002515 2013-05-14

Publications (1)

Publication Number Publication Date
TR201906195T4 true TR201906195T4 (tr) 2019-05-21

Family

ID=48428310

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/06195T TR201906195T4 (tr) 2013-05-14 2014-05-14 Niemann pıck hastalığının teşhisi için metot.

Country Status (10)

Country Link
US (1) US10302664B2 (https=)
EP (1) EP2997384B1 (https=)
JP (2) JP6660291B2 (https=)
CA (1) CA2912274A1 (https=)
CY (1) CY1121790T1 (https=)
DK (1) DK2997384T3 (https=)
ES (1) ES2731920T3 (https=)
SA (1) SA515370129B1 (https=)
TR (1) TR201906195T4 (https=)
WO (1) WO2014183873A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2762608T3 (es) * 2013-06-07 2020-05-25 Genzyme Corp Marcador para trastornos de esfingomielinasa ácida y usos del mismo
CA2967504A1 (en) * 2014-11-19 2016-05-26 Centogene Ag Method for the diagnosis of niemann-pick disease using a biomarker
US20210318324A1 (en) 2018-07-05 2021-10-14 The Board Of Regents Of The University Of Oklahoma Gene signatures for cancer characterization and methods of use
HUE071194T2 (hu) * 2019-05-31 2025-08-28 Genzyme Corp Kétdimenziós LC-MS/MS rendszerek

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9908190D0 (en) * 1999-04-09 1999-06-02 Pharming Intellectual Pty Bv Diagnosis of lysosomal storage disorders using saposins and other markers
GB0128498D0 (en) * 2001-11-28 2002-01-23 Inst Of Child Health International standards for sphingolipids
CA2524272A1 (en) * 2003-03-31 2004-10-14 Women's And Children's Hospital Multiplex screening for lysosomal storage disorders (lsds)
CN101214249A (zh) * 2003-11-25 2008-07-09 纽约大学西奈山医学院 尼曼-皮克病的基于陪伴分子的治疗
WO2007109881A1 (en) * 2006-03-24 2007-10-04 Phenomenome Discoveries Inc. Biomarkers useful for diagnosing prostate cancer, and methods thereof
US8497122B2 (en) * 2008-04-11 2013-07-30 Washington University Biomarkers for Niemann-pick C disease and related disorders
US8313949B2 (en) * 2009-04-16 2012-11-20 Nextcea Inc. Detecting phospholipidosis and diagnosing lysosomal storage disorders
SI3998078T1 (sl) * 2009-08-28 2026-02-27 Genzyme Corporation Encimsko nadomestno zdravljenje z naraščajočim odmerkom za zdravljenje pomanjkanja kisle sfingomielinaze

Also Published As

Publication number Publication date
JP2020101554A (ja) 2020-07-02
WO2014183873A1 (en) 2014-11-20
CY1121790T1 (el) 2020-07-31
DK2997384T3 (da) 2019-07-22
EP2997384A1 (en) 2016-03-23
SA515370129B1 (ar) 2019-11-18
JP2016522406A (ja) 2016-07-28
US10302664B2 (en) 2019-05-28
JP6989636B2 (ja) 2022-01-05
EP2997384B1 (en) 2019-04-10
CA2912274A1 (en) 2014-11-20
ES2731920T3 (es) 2019-11-19
US20160109470A1 (en) 2016-04-21
JP6660291B2 (ja) 2020-03-11

Similar Documents

Publication Publication Date Title
EA201590027A1 (ru) Способы детекции заболеваний или состояний
EA201600085A1 (ru) Набор для обнаружения соевого события syht0h2
MX367046B (es) Marcadores especificos de via para diagnosticar sindrome del intestino irritable.
MX390772B (es) Métodos para tratar cáncer y el uso de biomarcadores como predictor de sensibilidad clínica a terapias.
EA201290711A1 (ru) Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности
WO2015094995A3 (en) Gene signature biomarkers of tumor response to pd-1 antagonists
MX2018012580A (es) Métodos y kits para el diagnóstico y la estratificación de riesgo en pacientes con isquemia.
MX373248B (es) Prediccion de riesgo de evento cardiovascular y usos del mismo.
BR112014013082A2 (pt) método para detectar adutos nucleossomos
BR112012030587A2 (pt) métodos para diagnóstico de câncer pancreático, para identificar se um indivíduo precisa ou não de uma terapia contra câncer pancreático e para determinar se uma terapia contra câncer pancreático obtém sucesso, dispositivo para diagnóstico de câncer pancreático e uso de pelo menos um biomarcador
AR095363A1 (es) Biomarcadores y métodos para el tratamiento de condiciones relacionadas con pd-1 y pd-l1
EA201490999A1 (ru) Способ проведения количественных анализов
BRPI0915619A2 (pt) métodos para determinar uma probabilidade de que um sujeito tenha contribuído com material genético para amostra de teste de material genético, para caracterizar amostra de teste de material genético e para determinar se uma pessoa de interesse contribuiu com material genético para uma amostra de teste de material genético, kit para análise de amostra de teste de material genético e sistema para determinar se um sujeito contribuiu com material genético para uma amostra
EP2569635A4 (en) METHOD FOR DIAGNOSIS AND / OR TREATMENT OF ENZEPHALITIS OR EPILEPSY
EA201370063A1 (ru) Фосфолипидом рака
WO2016198833A3 (en) Methods for analysing a urine sample
TR201819546T4 (tr) Numune tür kökeni için tespit yöntemleri.
MX375421B (es) Metodos y equipos para predecir el riesgo de tener una enfermedad o evento cardiovascular.
CY1122360T1 (el) Μεθοδος για τη διαγνωση της νοσου niemann-pick
WO2011137388A3 (en) Identification and use of biomarkers for detection and quantification of the level of radiation exposure in a biological sample
MX360479B (es) Anticuerpos contra microbioma, factores de estres y marcadores de mastocitos como marcadores de diagnostico para ibs.
WO2015077382A3 (en) Combined cytology and molecular testing for early detection of esophageal adenocarcinoma
MX377026B (es) Biomarcadores para la progresión de enfermedades en melanoma.
TR201906195T4 (tr) Niemann pıck hastalığının teşhisi için metot.
MX385216B (es) Prueba de diagnostico basada en fragmento de rgma.